Margaret J. Dawson

发表

Manufacture of Clinical-Grade CD19-Specific T Cells Stably Expressing Chimeric Antigen Receptor Using Sleeping Beauty System and Artificial Antigen Presenting Cells

S. Olivares, Harjeet Singh, H. Huls, 2013, PloS one.

System Sleeping Beauty the Redirecting Specificity of T-cell Populations for Cd19 Using Cited Articles Citing Articles E-mail Alerts Redirecting Specificity of T-cell Populations for Cd19 Using the Sleeping Beauty System

E. Shpall, D. Kohn, P. Hackett, 2022 .

piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies.

P. Rao, E. Shpall, Y. Nakazawa, 2010, Human gene therapy.

Plasma Renin Activity in Acute Tubular Necrosis and Other Renal Diseases Associated with Hypertension

W. Tu, Margaret J. Dawson, 1965, Circulation.

Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells.

Katy Rezvani, David A Largaespada, Jianliang Dai, 2016, The Journal of clinical investigation.

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

E. Shpall, S. Olivares, Harjeet Singh, 2013, Journal of visualized experiments : JoVE.

Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies.

S. Olivares, Tiejuan Mi, K. Switzer, 2011, Cancer research.

Sleeping Beauty System to Redirect T-cell Specificity for Human Applications

A. Multani, P. Hackett, S. Ang, 2013, Journal of immunotherapy.

Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system.

E. Shpall, D. Kohn, P. Hackett, 2008, Cancer research.

30: A Fully-Human Chimeric Antigen Receptor for Redirecting Specificity of T Cells to B-Lineage Tumors

E. Shpall, S. Olivares, H. Huls, 2008 .